Analyst Price Targets — MD
Latest News for MD
Pediatrix Medical Group NYSE: MD reported third-quarter 2026 adjusted EBITDA of $85 million, with management saying results exceeded its expectations despite rising costs across healthcare delivery. The company narrowed its full-year adjusted EBITDA outlook to a range of $290 million to $300 million.
Pediatrix Medical Group, Inc. ( MD ) Q3 2026 Earnings Call October 29, 2026 9:00 AM EDT Company Participants David Haddock - Executive Vice President, General Counsel & Secretary Mark Ordan - CEO & Executive Chairman Kasandra Rossi - Executive VP, Treasurer & CFO Conference Call Participants Matthew Mardula - William Blair & Company L.L.C., Research Division Albert Rice - UBS Investment Bank, Research Division Jack…
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.67 per share a year ago.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.